Matthew Smeltzer advances population-based and real-world evidence in thoracic oncology, focusing on biomarker testing adoption, screening effectiveness, surgical quality standards, and disparities. Collaborates with IASLC and health systems to translate data into measurable improvements in lung cancer care.